Prostate Cancer Staging Overview | Mark Scholz, MD 2014

Рет қаралды 48,847

Күн бұрын

Dr. Mark Scholz discussed "Prostate Cancer Staging" and the Prostate Cancer Conference, New Mexico. This video was brought to you by The Prostate Cancer Support Association of New Mexico. pcsanm.org
The information on the Prostate Cancer Research Institute's KZfaq channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD

Пікірлер: 33

@eddiegardner8232 2 жыл бұрын

One of your best lectures ever; still relevant today.

@ThePCRI 2 жыл бұрын

Thanks Eddie!

@artmaltman 3 жыл бұрын

This talk from 2015 is fantastic! Comprehensive and clear. Today its almost December 2020. What would be different if you gave this talk today? Is there a newer version of this talk? My personal interest is high risk Teal (and I am already getting excellent assistance from Jonathan on the PCRI help line!) but regardless I am sure that many of us would like to see an update on this talk if much has changed. Thanks!!!

@4264speed 3 жыл бұрын

I wish I had seen this before I started my treatment this is a wealth of information so much to learn to help guide you thru treatment

@briangriffith2394 3 жыл бұрын

Thank you doctor for all your information

@affiliateinternetmarketing9980 3 жыл бұрын

This is an eye opener for me. I am preparing a video about Prostate cancer, and I wish you let me use your video in my project.

@ThePCRI 3 жыл бұрын

Hi, no problem. Thank you for asking.

@fawwazabu 2 жыл бұрын

Is there an updated version of this staging lecture we are in 2022

@waynelast1685 3 жыл бұрын

My understanding is this ( please confirm if you want) : also add PSA velocity ( doubling time) and margin result ( positive/negative) if surgery biopsy is possible.

@artmaltman 3 жыл бұрын

Why not SBRT for high risk teal?

@waynelast1685 3 жыл бұрын

I am not sure this grading system is accepted practice today. I am not the expert but your risk assessment is not based on this tidy rows of values. For example my other research indicates a “TEAL” level could be based on local therapy OR GLEASON score OR digital rectal OR PSA... something like that. Not sure of the most current accepted practice. Some other experts please advise.

@glenbearh9109 3 жыл бұрын

I have 8 of 12 cores with G6 but upon second opinion, one of the eight was graded 7 one had 50% another 25% the rest were very low 1% to 5% I think brachytherapy is in store. I failed taking an MRI because of severe anxiety disorder, sleep apnea and severe pain when I lie on my back. Excluding getting a CPAP hose into the MRI room, I may not be able to have treatment-except surgery which I do not want. Is it possible to do brachy or SBRT without an MRI? maybe using the biopsy template and CT scan?

@glenbearh9109 3 жыл бұрын

Add that PSA is 5.1 and is normal for me to be between 4.1 and 5.5 due to very large prostate. DRE showed no tumor.

@ThePCRI 3 жыл бұрын

Hello, our prostate cancer helpline may be able to help with your question. Please feel free to contact us here: pcri.org/helpline

@ransomcoates546 2 жыл бұрын

@@glenbearh9109 Why not have the MRI under anesthesia?

@glenbearh9109 2 жыл бұрын

@@ransomcoates546 I was sedated but stopped breathing in the tube due to sleep apnea so they woke me up by stopping the profolol-I was in the darn tube and freaked out.

@ransomcoates546 2 жыл бұрын

@@glenbearh9109 What an ordeal. I’m lucky to find MRI’s an excuse to nap. I hope all the best for you fighting this disease. My biopsy is in a couple of weeks. Really anxious to avoid surgery.

@waynelast1685 3 жыл бұрын

chabshey From my research there IS a gaping hole in a lot of the research studies that do not properly address longer periods of recovery after RP or IMRT. Perhaps because they do not have adequate data or perhaps the cancer is bound to return no matter what treatment you have. I am not sure yet. But you should think of quality of life too. The better centers have fairly sophisticated radiation procedures now and have almost identical survival and progression free rates after 5 and 10 years. I myself am leaning towards getting radiation as I am 62 years old. Incontinence and ED are two side effects from surgery more expressed with surgery than radiation. However, one drawback of radiation is not as easily detected or as early , compared to surgery. And from my understanding the cancer can come back inside the radiated prostate since maybe not all the cancer cells were killed. That is my conundrum now. Any words of advise from others will be greatly appreciated .

@peacefulruler1 3 жыл бұрын

Brachytherapy puts higher dose radiation within the prostate, not going outside so one would expect the cancer cells to much more effectively killed compared to external beam. Adding TIP/ADT weakens the ability of the cancer cells to fix themselves after radiation damage. I’m also taking other supplements and am vegan to further tip the scales in my favor.

@charleswells8008 3 жыл бұрын

Can you get more of benefits from the social security for this disease

@peacefulruler1 3 жыл бұрын

No.

@r9z 3 жыл бұрын

Kokomo. Ono Mk koko o on.

@sandraredmond4812 Жыл бұрын

Why has mayo stopped doing brachytherapy?

@princesethi7655 3 жыл бұрын

Hi Sir, I m from India. My father is suffering from prostate cancer. As per pet scan report the cancer is in grade 4 state. Now doctor did the surgery and told me that cancer can't be cure in this stage and my father is having only 2 years. Can you please provide me your contact details so that I can send all reports and suggest me if there is any chance to cure his cancer.

@peacefulruler1 3 жыл бұрын

There are doctors who treat metastatic cancer. Contact Dr Eugene Kwon at Mayo Clinic. www.healthgrades.com/physician/dr-eugene-kwon-xqjmw Stop all dairy and meat; join Facebook groups like Jane McLelland, mycancerstory.rocks, and Care Oncology.